NewGenIvf Group Limited (NASDAQ: NIVF) Stock Competitors & Peer Comparison
See NIVF's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NIVF and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NIVF | $0.85 | -8.18% | 159.8K | 0.42 | $2.03 | N/A |
| HCA | $408.18 | -2.39% | 90.6B | 14.10 | $28.96 | +0.74% |
| THC | $257.62 | -1.91% | 22.2B | 14.95 | $17.24 | N/A |
| DVA | $240.96 | +0.63% | 15.5B | 20.54 | $11.73 | N/A |
| SOLV | $88.55 | +2.76% | 15.3B | 14.19 | $6.24 | N/A |
| FMS | $24.86 | +0.44% | 13.4B | 9.87 | $2.52 | +3.47% |
| EHC | $113.80 | -1.92% | 11.3B | 20.00 | $5.69 | +0.67% |
| ENSG | $181.89 | -0.68% | 10.6B | 26.36 | $6.90 | +0.14% |
| UHS | $168.16 | +1.17% | 10.2B | 7.45 | $22.54 | +0.48% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
NIVF vs HCA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, HCA has a market cap of 90.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while HCA trades at $408.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas HCA's P/E ratio is 14.10. In terms of profitability, NIVF's ROE is +0.33%, compared to HCA's ROE of -1.13%. Regarding short-term risk, NIVF is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
NIVF vs THC Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, THC has a market cap of 22.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while THC trades at $257.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas THC's P/E ratio is 14.95. In terms of profitability, NIVF's ROE is +0.33%, compared to THC's ROE of +0.51%. Regarding short-term risk, NIVF is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check THC's competition here
DaVita Inc. (NYSE: DVA)
NIVF vs DVA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, DVA has a market cap of 15.5B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while DVA trades at $240.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas DVA's P/E ratio is 20.54. In terms of profitability, NIVF's ROE is +0.33%, compared to DVA's ROE of -1.33%. Regarding short-term risk, NIVF is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
NIVF vs SOLV Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SOLV trades at $88.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SOLV's P/E ratio is 14.19. In terms of profitability, NIVF's ROE is +0.33%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, NIVF is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
NIVF vs FMS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while FMS trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas FMS's P/E ratio is 9.87. In terms of profitability, NIVF's ROE is +0.33%, compared to FMS's ROE of +0.07%. Regarding short-term risk, NIVF is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
NIVF vs EHC Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, EHC has a market cap of 11.3B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while EHC trades at $113.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas EHC's P/E ratio is 20.00. In terms of profitability, NIVF's ROE is +0.33%, compared to EHC's ROE of +0.25%. Regarding short-term risk, NIVF is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
NIVF vs ENSG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ENSG trades at $181.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ENSG's P/E ratio is 26.36. In terms of profitability, NIVF's ROE is +0.33%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, NIVF is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
NIVF vs UHS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, UHS has a market cap of 10.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while UHS trades at $168.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas UHS's P/E ratio is 7.45. In terms of profitability, NIVF's ROE is +0.33%, compared to UHS's ROE of +0.21%. Regarding short-term risk, NIVF is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
NIVF vs OSH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas OSH's P/E ratio is -17.65. In terms of profitability, NIVF's ROE is +0.33%, compared to OSH's ROE of +4.64%. Regarding short-term risk, NIVF is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
NIVF vs PACS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while PACS trades at $46.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas PACS's P/E ratio is 39.49. In terms of profitability, NIVF's ROE is +0.33%, compared to PACS's ROE of +0.27%. Regarding short-term risk, NIVF is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
NIVF vs CHE Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CHE has a market cap of 7.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CHE trades at $539.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CHE's P/E ratio is 24.99. In terms of profitability, NIVF's ROE is +0.33%, compared to CHE's ROE of +0.29%. Regarding short-term risk, NIVF is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
NIVF vs LHCG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas LHCG's P/E ratio is 82.83. In terms of profitability, NIVF's ROE is +0.33%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, NIVF is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
NIVF vs LFST Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while LFST trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas LFST's P/E ratio is 173.01. In terms of profitability, NIVF's ROE is +0.33%, compared to LFST's ROE of +0.02%. Regarding short-term risk, NIVF is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
NIVF vs CON Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CON has a market cap of 4B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CON's P/E ratio is 21.94. In terms of profitability, NIVF's ROE is +0.33%, compared to CON's ROE of +0.46%. Regarding short-term risk, NIVF is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
NIVF vs OPCH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, OPCH has a market cap of 3.8B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while OPCH trades at $23.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas OPCH's P/E ratio is 13.91. In terms of profitability, NIVF's ROE is +0.33%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, NIVF is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
NIVF vs NHC Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while NHC trades at $228.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas NHC's P/E ratio is 32.86. In terms of profitability, NIVF's ROE is +0.33%, compared to NHC's ROE of +0.12%. Regarding short-term risk, NIVF is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check NHC's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
NIVF vs BKD Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, BKD has a market cap of 3.5B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while BKD trades at $14.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas BKD's P/E ratio is -25.63. In terms of profitability, NIVF's ROE is +0.33%, compared to BKD's ROE of +401.19%. Regarding short-term risk, NIVF is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check BKD's competition here
Amedisys, Inc. (NASDAQ: AMED)
NIVF vs AMED Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AMED's P/E ratio is 39.30. In terms of profitability, NIVF's ROE is +0.33%, compared to AMED's ROE of +0.11%. Regarding short-term risk, NIVF is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
NIVF vs ACHC Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ACHC trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ACHC's P/E ratio is 13.74. In terms of profitability, NIVF's ROE is +0.33%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, NIVF is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
NIVF vs ADUS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ADUS trades at $119.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ADUS's P/E ratio is 18.50. In terms of profitability, NIVF's ROE is +0.33%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, NIVF is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
NIVF vs MD Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while MD trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas MD's P/E ratio is 12.49. In terms of profitability, NIVF's ROE is +0.33%, compared to MD's ROE of +0.20%. Regarding short-term risk, NIVF is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check MD's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
NIVF vs SGRY Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SGRY trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SGRY's P/E ratio is 42.08. In terms of profitability, NIVF's ROE is +0.33%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, NIVF is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
NIVF vs AVAH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AVAH trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AVAH's P/E ratio is 14.34. In terms of profitability, NIVF's ROE is +0.33%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, NIVF is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AVAH's competition here
Select Medical Holdings Corporation (NYSE: SEM)
NIVF vs SEM Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SEM has a market cap of 2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SEM's P/E ratio is 15.43. In terms of profitability, NIVF's ROE is +0.33%, compared to SEM's ROE of +0.08%. Regarding short-term risk, NIVF is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SEM's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
NIVF vs AMEH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AMEH's P/E ratio is 39.25. In terms of profitability, NIVF's ROE is +0.33%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, NIVF is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
NIVF vs ASTH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ASTH trades at $36.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ASTH's P/E ratio is 24.67. In terms of profitability, NIVF's ROE is +0.33%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, NIVF is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
NIVF vs HCSG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while HCSG trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas HCSG's P/E ratio is 18.74. In terms of profitability, NIVF's ROE is +0.33%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, NIVF is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
NIVF vs ARDT Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ARDT trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ARDT's P/E ratio is 6.66. In terms of profitability, NIVF's ROE is +0.33%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, NIVF is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
NIVF vs INNV Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while INNV trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas INNV's P/E ratio is -127.44. In terms of profitability, NIVF's ROE is +0.33%, compared to INNV's ROE of -0.09%. Regarding short-term risk, NIVF is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check INNV's competition here
Agilon Health, Inc. (NYSE: AGL)
NIVF vs AGL Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AGL trades at $92.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AGL's P/E ratio is -9.13. In terms of profitability, NIVF's ROE is +0.33%, compared to AGL's ROE of -1.46%. Regarding short-term risk, NIVF is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AGL's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
NIVF vs CMPS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CMPS has a market cap of 1.5B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CMPS trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CMPS's P/E ratio is -5.32. In terms of profitability, NIVF's ROE is +0.33%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, NIVF is more volatile compared to CMPS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CMPS's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
NIVF vs PNTG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while PNTG trades at $41.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas PNTG's P/E ratio is 33.40. In terms of profitability, NIVF's ROE is +0.33%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, NIVF is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
NIVF vs AMN Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AMN trades at $34.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AMN's P/E ratio is 11.51. In terms of profitability, NIVF's ROE is +0.33%, compared to AMN's ROE of -0.05%. Regarding short-term risk, NIVF is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
NIVF vs BKDT Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas BKDT's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, NIVF is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
NIVF vs USPH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while USPH trades at $79.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas USPH's P/E ratio is 30.75. In terms of profitability, NIVF's ROE is +0.33%, compared to USPH's ROE of +0.00%. Regarding short-term risk, NIVF is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check USPH's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
NIVF vs NUTX Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, NUTX has a market cap of 966.8M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while NUTX trades at $140.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas NUTX's P/E ratio is 10.86. In terms of profitability, NIVF's ROE is +0.33%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, NIVF is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check NUTX's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
NIVF vs FSHCX Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, FSHCX has a market cap of 906.7M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while FSHCX trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas FSHCX's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to FSHCX's ROE of N/A. Regarding short-term risk, NIVF is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALK)
NIVF vs TALK Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TALK has a market cap of 874.4M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TALK trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TALK's P/E ratio is 769.91. In terms of profitability, NIVF's ROE is +0.33%, compared to TALK's ROE of +0.01%. Regarding short-term risk, NIVF is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TALK's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
NIVF vs SNDA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SNDA has a market cap of 815.1M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SNDA trades at $40.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SNDA's P/E ratio is -7.55. In terms of profitability, NIVF's ROE is +0.33%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, NIVF is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
NIVF vs EHAB Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas EHAB's P/E ratio is -197.14. In terms of profitability, NIVF's ROE is +0.33%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, NIVF is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
NIVF vs GMRS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, GMRS has a market cap of 593.1M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while GMRS trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas GMRS's P/E ratio is 5.76. In terms of profitability, NIVF's ROE is +0.33%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, NIVF is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
NIVF vs TOIIW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TOIIW has a market cap of 490.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, NIVF's ROE is +0.33%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, NIVF is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TOIIW's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
NIVF vs TOI Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TOI has a market cap of 476.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TOI trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TOI's P/E ratio is -13.25. In terms of profitability, NIVF's ROE is +0.33%, compared to TOI's ROE of +3.27%. Regarding short-term risk, NIVF is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
NIVF vs VMD Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, VMD has a market cap of 446.6M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while VMD trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas VMD's P/E ratio is 31.49. In terms of profitability, NIVF's ROE is +0.33%, compared to VMD's ROE of +0.11%. Regarding short-term risk, NIVF is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
NIVF vs MCTA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas MCTA's P/E ratio is 419.36. In terms of profitability, NIVF's ROE is +0.33%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, NIVF is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
NIVF vs SRTA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SRTA has a market cap of 421.4M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SRTA trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SRTA's P/E ratio is -34.26. In terms of profitability, NIVF's ROE is +0.33%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, NIVF is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
NIVF vs AUNA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AUNA has a market cap of 384.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AUNA trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AUNA's P/E ratio is 4.68. In terms of profitability, NIVF's ROE is +0.33%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, NIVF is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
NIVF vs CYH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CYH has a market cap of 382.1M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CYH trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CYH's P/E ratio is 3.71. In terms of profitability, NIVF's ROE is +0.33%, compared to CYH's ROE of +0.21%. Regarding short-term risk, NIVF is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CYH's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
NIVF vs AIRS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AIRS has a market cap of 307.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AIRS trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AIRS's P/E ratio is -145.17. In terms of profitability, NIVF's ROE is +0.33%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, NIVF is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
NIVF vs CSU Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CSU's P/E ratio is 0.67. In terms of profitability, NIVF's ROE is +0.33%, compared to CSU's ROE of -0.51%. Regarding short-term risk, NIVF is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
NIVF vs JYNT Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, JYNT has a market cap of 118.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while JYNT trades at $8.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas JYNT's P/E ratio is 83.40. In terms of profitability, NIVF's ROE is +0.33%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, NIVF is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
NIVF vs FVE Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas FVE's P/E ratio is -5.64. In terms of profitability, NIVF's ROE is +0.33%, compared to FVE's ROE of -0.15%. Regarding short-term risk, NIVF is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
NIVF vs KDLYW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas KDLYW's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, NIVF is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
NIVF vs BTMD Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, BTMD has a market cap of 90M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while BTMD trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas BTMD's P/E ratio is 4.64. In terms of profitability, NIVF's ROE is +0.33%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, NIVF is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
NIVF vs DCGO Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, DCGO has a market cap of 64.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while DCGO trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas DCGO's P/E ratio is -0.75. In terms of profitability, NIVF's ROE is +0.33%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, NIVF is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
NIVF vs ALR Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ALR's P/E ratio is -1.11. In terms of profitability, NIVF's ROE is +0.33%, compared to ALR's ROE of -0.15%. Regarding short-term risk, NIVF is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
NIVF vs PARK Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, PARK has a market cap of 35M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while PARK trades at $17.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas PARK's P/E ratio is 24.30. In terms of profitability, NIVF's ROE is +0.33%, compared to PARK's ROE of -0.24%. Regarding short-term risk, NIVF is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check PARK's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
NIVF vs PIII Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, PIII has a market cap of 34.8M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while PIII trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas PIII's P/E ratio is -0.27. In terms of profitability, NIVF's ROE is +0.33%, compared to PIII's ROE of +1.85%. Regarding short-term risk, NIVF is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
NIVF vs IMAC Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas IMAC's P/E ratio is -2.27. In terms of profitability, NIVF's ROE is +0.33%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, NIVF is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
NIVF vs CCEL Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CCEL has a market cap of 28.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CCEL trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CCEL's P/E ratio is -10.61. In terms of profitability, NIVF's ROE is +0.33%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, NIVF is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
NIVF vs CANO-WT Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, NIVF is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
NIVF vs AIH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AIH's P/E ratio is -2.78. In terms of profitability, NIVF's ROE is +0.33%, compared to AIH's ROE of +1.16%. Regarding short-term risk, NIVF is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
NIVF vs CANO Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CANO's P/E ratio is -0.01. In terms of profitability, NIVF's ROE is +0.33%, compared to CANO's ROE of -1.49%. Regarding short-term risk, NIVF is more volatile compared to CANO. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CANO's competition here
American Shared Hospital Services (AMEX: AMS)
NIVF vs AMS Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AMS has a market cap of 10.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AMS trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AMS's P/E ratio is -7.10. In terms of profitability, NIVF's ROE is +0.33%, compared to AMS's ROE of -0.06%. Regarding short-term risk, NIVF is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AMS's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
NIVF vs FPCG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas FPCG's P/E ratio is 0.09. In terms of profitability, NIVF's ROE is +0.33%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, NIVF is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
NIVF vs FTRP Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas FTRP's P/E ratio is -1.22. In terms of profitability, NIVF's ROE is +0.33%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, NIVF is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
NIVF vs BMGL Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, BMGL has a market cap of 8.9M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while BMGL trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas BMGL's P/E ratio is -1.08. In terms of profitability, NIVF's ROE is +0.33%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, NIVF is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
NIVF vs XWEL Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, XWEL has a market cap of 6.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while XWEL trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas XWEL's P/E ratio is -0.32. In terms of profitability, NIVF's ROE is +0.33%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, NIVF is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
NIVF vs MODV Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas MODV's P/E ratio is -0.06. In terms of profitability, NIVF's ROE is +0.33%, compared to MODV's ROE of +1.36%. Regarding short-term risk, NIVF is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
NIVF vs GBNH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas GBNH's P/E ratio is -0.06. In terms of profitability, NIVF's ROE is +0.33%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, NIVF is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
NIVF vs RHE-PA Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, NIVF's ROE is +0.33%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, NIVF is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
NIVF vs RHE Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas RHE's P/E ratio is -1.79. In terms of profitability, NIVF's ROE is +0.33%, compared to RHE's ROE of -0.36%. Regarding short-term risk, NIVF is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check RHE's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
NIVF vs AIDX Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AIDX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AIDX's P/E ratio is -0.83. In terms of profitability, NIVF's ROE is +0.33%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, NIVF is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
NIVF vs IMACW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas IMACW's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, NIVF is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
NIVF vs NAKAW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, NIVF's ROE is +0.33%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, NIVF is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
NIVF vs CCM Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while CCM trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas CCM's P/E ratio is -0.30. In terms of profitability, NIVF's ROE is +0.33%, compared to CCM's ROE of +0.06%. Regarding short-term risk, NIVF is more volatile compared to CCM. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check CCM's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
NIVF vs MNDR Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, MNDR has a market cap of 41.1K. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while MNDR trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas MNDR's P/E ratio is -0.04. In terms of profitability, NIVF's ROE is +0.33%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, NIVF is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
NIVF vs NIVFW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, NIVFW has a market cap of 39.1K. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, NIVF's ROE is +0.33%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, NIVF is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
NIVF vs TALKW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TALKW's P/E ratio is 0.00. In terms of profitability, NIVF's ROE is +0.33%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, NIVF is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check TALKW's competition here
DocGo Inc. (NASDAQ: DCGOW)
NIVF vs DCGOW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas DCGOW's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, NIVF is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
NIVF vs TLMDW Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TLMDW's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, NIVF is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
NIVF vs HNGR Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, HNGR has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas HNGR's P/E ratio is 19.71. In terms of profitability, NIVF's ROE is +0.33%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, NIVF is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
NIVF vs ATIP-WT Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, NIVF is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for NIVF.Check ATIP-WT's competition here
New Frontier Health Corporation (NYSE: NFH)
NIVF vs NFH Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, NFH has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas NFH's P/E ratio is -19.75. In terms of profitability, NIVF's ROE is +0.33%, compared to NFH's ROE of -0.06%. Regarding short-term risk, NIVF is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check NFH's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
NIVF vs DVCR Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, DVCR has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas DVCR's P/E ratio is 28.34. In terms of profitability, NIVF's ROE is +0.33%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, NIVF is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check DVCR's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
NIVF vs SLHGP Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, NIVF's ROE is +0.33%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, NIVF is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
NIVF vs SLHG Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, SLHG has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas SLHG's P/E ratio is -1.48. In terms of profitability, NIVF's ROE is +0.33%, compared to SLHG's ROE of N/A. Regarding short-term risk, NIVF is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
NIVF vs AFAM Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, AFAM has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas AFAM's P/E ratio is N/A. In terms of profitability, NIVF's ROE is +0.33%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, NIVF is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
NIVF vs TLMD Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TLMD has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TLMD's P/E ratio is -1.60. In terms of profitability, NIVF's ROE is +0.33%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, NIVF is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TLMD's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
NIVF vs TVTY Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, TVTY has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas TVTY's P/E ratio is 19.06. In terms of profitability, NIVF's ROE is +0.33%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, NIVF is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check TVTY's competition here
Kindred Healthcare, Inc. (NYSE: KND)
NIVF vs KND Comparison July 2026
NewGenIvf Group Limited (NASDAQ: NIVF) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NIVF stands at 159.8K. In comparison, KND has a market cap of 0. Regarding current trading prices, NIVF is priced at $0.85 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NIVF currently has a P/E ratio of 0.42, whereas KND's P/E ratio is -1.14. In terms of profitability, NIVF's ROE is +0.33%, compared to KND's ROE of -0.53%. Regarding short-term risk, NIVF is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for NIVF.Check KND's competition here